The Claim

Polyendocrine metabolic ovarian syndrome, affecting 10–13% of women globally, is associated with increased risks of gestational diabetes mellitus, hypertensive disorders including pre-eclampsia, preterm birth, fetal growth restriction, and low birth weight during pregnancy, due to underlying hyperinsulinaemia, hyperandrogenism, and frequent pre-pregnancy obesity.

Source: Polyendocrine metabolic ovarian syndrome in pregnancy: pathophysiology and outcomes.

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
1score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Women with polyendocrine metabolic ovarian syndrome have higher rates of gestational diabetes, high blood pressure during pregnancy, preterm birth, restricted fetal growth, and low birth weight, due to elevated insulin levels, high androgen levels, and common pre-pregnancy obesity.

See the scientific wording

Polyendocrine metabolic ovarian syndrome (PMOS), affecting 10–13% of women globally, is associated with increased risks of gestational diabetes mellitus, hypertensive disorders including pre-eclampsia, preterm birth, fetal growth restriction, and low birth weight during pregnancy, due to underlying hyperinsulinaemia, hyperandrogenism, and frequent pre-pregnancy obesity.

Why this might work

Excess insulin in the body causes the ovaries to make too many male hormones, which disrupts normal egg development. When a woman with this condition becomes pregnant, her body cannot handle the extra insulin resistance caused by pregnancy, leading to high blood sugar. At the same time, the excess male hormones and fat tissue trigger inflammation and damage blood vessels in the placenta. This prevents the placenta from delivering enough nutrients and oxygen to the baby, causing the baby to grow too slowly, be born early, or have low birth weight. The mother also develops high blood pressure and diabetes because her blood vessels and metabolism are overwhelmed.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Polyendocrine metabolic ovarian syndrome in pregnancy: pathophysiology and outcomes.

    Women with PMOS are more likely to have problems during pregnancy like high blood pressure, diabetes, early birth, or small babies — and this study confirms it, saying it’s because of insulin issues, too many male hormones, and often being overweight before pregnancy.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.